Evan Anthony Jones
#160,357
Most Influential Person Now
Evan Anthony Jones's AcademicInfluence.com Rankings
Download Badge
Biology
Why Is Evan Anthony Jones Influential?
(Suggest an Edit or Addition)Evan Anthony Jones's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Psychiatric complications of long-term interferon alfa therapy. (1987) (409)
- Itch: scratching more than the surface. (2003) (378)
- Histopathology and prognosis of malignant colorectal polyps treated by endoscopic polypectomy. (1984) (365)
- HEPATIC ENCEPHALOPATHY AND THE γ-AMINOBUTYRIC-ACID NEUROTRANSMITTER SYSTEM (1982) (263)
- The mechanism of intestinal uptake and transcellular transport of IgG in the neonatal rat. (1972) (261)
- Primary Biliary Cirrhosis: A Model Autoimmune Disease (1983) (188)
- The Budd-Chiari syndrome: correlation between hepatic scintigraphy and the clinical, radiological, and pathological findings in nineteen cases of hepatic venous outflow obstruction. (1975) (171)
- Lipoprotein abnormalities in primary biliary cirrhosis. Association with hepatic lipase inhibition as well as altered cholesterol esterification. (1985) (168)
- Endogenous opioids accumulate in plasma in a rat model of acute cholestasis. (1992) (165)
- The Neurobiology of Hepatic Encephalopathy (1984) (162)
- Spectrum of anemia associated with chronic liver disease. (2009) (162)
- Elevated brain concentrations of 1,4-benzodiazepines in fulminant hepatic failure. (1991) (141)
- Oral nalmefene therapy reduces scratching activity due to the pruritus of cholestasis: a controlled study. (1999) (140)
- Amelioration of hepatic encephalopathy by pharmacologic antagonism of the GABAA-benzodiazepine receptor complex in a rabbit model of fulminant hepatic failure. (1987) (136)
- The pathogenesis and treatment of hepatic encephalopathy: evidence for the involvement of benzodiazepine receptor ligands. (1991) (135)
- Neurology and the liver (1997) (128)
- Central mu-opioid receptors are down-regulated in a rat model of cholestasis. (1992) (126)
- A model of fulminant hepatic failure in the rabbit (1978) (124)
- COULD AN ENDOGENOUS BENZODIAZEPINE LIGAND CONTRIBUTE TO HEPATIC ENCEPHALOPATHY? (1988) (123)
- The pruritus of cholestasis: potential pathogenic and therapeutic implications of opioids. (1995) (119)
- Cholestasis in the male rat is associated with naloxone-reversible antinociception. (1994) (114)
- Visual evoked potentials in a rabbit model of hepatic encephalopathy. I. Sequential changes and comparisons with drug-induced comas. (1984) (109)
- Gamma-aminobutyric acid and benzodiazepine receptors in an animal model of fulminant hepatic failure. (1983) (106)
- Receptor specific clearance by the reticuloendothelial system in chronic liver diseases. Demonstration of defective C3b-specific clearance in primary biliary cirrhosis. (1978) (101)
- Suppression of hypothalamic-pituitary-adrenal axis responsiveness to stress in a rat model of acute cholestasis. (1993) (100)
- Opiate antagonist therapy for the pruritus of cholestasis: the avoidance of opioid withdrawal-like reactions. (2002) (99)
- Deficiency of the autologous mixed lymphocyte reaction in patients with primary biliary cirrhosis. (1980) (89)
- Abnormal regulation of immunoglobulin synthesis in vitro in primary biliary cirrhosis (1980) (87)
- Enhanced intrahepatic inducible nitric oxide synthase expression and nitrotyrosine accumulation in primary biliary cirrhosis and autoimmune hepatitis. (2002) (86)
- Cholestasis is associated with preproenkephalin mRNA expression in the adult rat liver. (1995) (86)
- Increased blood-brain transfer in a rabbit model of acute liver failure (1983) (86)
- The uptake of native and desialylated glucocerebrosidase by rat hepatocytes and Kupffer cells. (1978) (85)
- SERUM LEVELS OF GAMMA-AMINOBUTYRIC-ACID-LIKE ACTIVITY IN ACUTE AND CHRONIC HEPATOCELLULAR DISEASE (1983) (81)
- Relief from profound fatigue associated with chronic liver disease by long-term ondansetron therapy (1999) (80)
- The pruritus of cholestasis and the opioid system. (1992) (80)
- Ammonia, the GABA Neurotransmitter System, and Hepatic Encephalopathy (2002) (79)
- Cytokine mRNA expression in the liver of patients with primary biliary cirrhosis (PBC) and chronic hepatitis B (CHB) (1996) (78)
- Protein metabolism in the intestinal stagnant loop syndrome. (1968) (75)
- Liver disease and erythropoietic protoporphyria: a concise review. (2010) (74)
- Brain concentrations of benzodiazepines are elevated in an animal model of hepatic encephalopathy. (1990) (73)
- Vitamin E deficiency in adults with chronic liver disease. (1985) (72)
- Modulation of a glycoprotein recognition system on rat hepatic endothelial cells by glucose and diabetes mellitus. (1982) (72)
- Evolving concepts of the pathogenesis and treatment of the pruritus of cholestasis. (2000) (72)
- Treatment of chronic non‐A, non‐B hepatitis with acyclovir: Pilot study (1985) (71)
- Gut bacteria provide precursors of benzodiazepine receptor ligands in a rat model of hepatic encephalopathy (1995) (71)
- Florid opioid withdrawal-like reaction precipitated by naltrexone in a patient with chronic cholestasis. (2000) (69)
- Synthesis of antibodies to hepatitis B virus by cultured lymphocytes from chronic hepatitis B surface antigen carriers. (1983) (68)
- Changes in the Status of Neurotransmitter Receptors in a Rabbit Model of Hepatic Encephalopathy (1984) (67)
- Pruritus and fatigue in primary biliary cirrhosis. (2003) (66)
- Hepatic coma due to acute hepatic necrosis treated by exchange blood-transfusion. (1967) (64)
- Plasma from patients with the pruritus of cholestasis induces opioid receptor-mediated scratching in monkeys. (1993) (63)
- Massive infection with Fasciola hepatica in man. (1977) (61)
- Angiogenesis: From Chronic Liver Inflammation to Hepatocellular Carcinoma (2010) (60)
- Application of piezo film technology for the quantitative assessment of pruritus. (1991) (59)
- Liver transplantation for intractable pruritus is contraindicated before an adequate trial of opiate antagonist therapy (2001) (57)
- Visual evoked potentials in a rabbit model of hepatic encephalopathy. II. Comparison of hyperammonemic encephalopathy, postictal coma, and coma induced by synergistic neurotoxins. (1984) (57)
- Abnormal clearance of immune complexes from the circulation of patients with primary sclerosing cholangitis. (1985) (56)
- Serum complement in chronic liver disease (1973) (56)
- Hepatic concentrations of proenkephalin-derived opioids are increased in a rat model of cholestasis. (2008) (55)
- Increased blood-brain transfer in a rabbit model of acute liver failure. (1983) (54)
- Hepatic encephalopathy and the gamma-aminobutyric-acid neurotransmitter system. (1982) (53)
- Increased brain uptake of γ-aminobutyric acid in a rabbit model of hepatic encephalopathy (1990) (53)
- Application of TOF-SIMS with chemometrics to discriminate between four different yeast strains from the species Candida glabrata and Saccharomyces cerevisiae. (2005) (52)
- Hypercatabolism of the third component of complement in patients with primary biliary cirrhosis. (1976) (52)
- Ondansetron and pruritus in chronic liver disease: a controlled study. (2007) (49)
- Lipoprotein abnormalities in primary biliary cirrhosis (1985) (48)
- Natural benzodiazepines and hepatic encephalopathy. (1996) (48)
- Management of the pruritus of cholestasis: potential role of opiate antagonists. (1991) (48)
- Biliary secretion in a patient with cystic dilation of the intrahepatic biliary tree. (1968) (46)
- Augmentation of albumin but not fibrinogen synthesis by corticosteroids in patients with hepatocellular disease. (1970) (46)
- Hepatic encephalopathy. Application of visual evoked responses to test hypotheses of its pathogenesis in rats. (1987) (43)
- Progressive intrahepatic cholestasis of infancy and childhood. A clinicopathological study of patient surviving to the age of 18 years. (1976) (42)
- Selective hepatic uptake of human beta-hexosaminidase A by a specific glycoprotein recognition system on sinusoidal cells. (1979) (41)
- Bacteraemia in association with hepatocellular and hepatobiliary disease. (1967) (40)
- A model of fulminant hepatic failure in the rabbit. (1978) (40)
- In vitro cell-mediated cytotoxicity in primary biliary cirrhosis and chronic hepatitis. Dysfunction of spontaneous cell-mediated cytotoxicity in primary biliary cirrhosis. (1977) (39)
- Theories of the pathogenesis of hepatic encephalopathy. (2012) (38)
- Fatigue Complicating Chronic Liver Disease (2004) (36)
- Does Ammonia Contribute to Increased GABA-ergic Neurotransmission in Liver Failure? (1998) (35)
- Brain and plasma levels of opioid peptides are altered in rats with thioacetamide-induced fulminant hepatic failure: implications for the treatment of hepatic encephalopathy with opioid antagonists. (1995) (33)
- Quantitative studies of the delivery of hepatic-synthesized bilirubin to plasma utilizing -aminolevulinic acid-4- 14 C and bilirubin- 3 H in man. (1972) (33)
- The pruritus of cholestasis. (1993) (31)
- Selective immunoglobulin A deficiency associated with primary biliary cirrhosis in a family with liver disease. (1986) (30)
- Combination therapy with mycophenolate mofetil and ursodeoxycholic acid for primary biliary cirrhosis. (1999) (30)
- Intestinal malabsorption of vitamin E in primary biliary cirrhosis. (1989) (29)
- Circulating immune complexes: their detection and potential significance in some hepatobiliary and intestinal diseases. (1980) (29)
- Adrenal secretion of BAM-22P, a potent opioid peptide, is enhanced in rats with acute cholestasis. (1994) (29)
- NIH conference. The gamma-aminobutyric acid A (GABAA) receptor complex and hepatic encephalopathy. Some recent advances. (1989) (29)
- The measurement of the synthetic rate of bilirubin from hepatic hemes in patients with acute intermittent porphyria. (1971) (29)
- The role of cell-surface receptors in the transport and catabolism of immunoglobulins. (1972) (29)
- Primary biliary cirrhosis and liver transplantation. (1982) (28)
- Autoradiographic analysis of GABA‐benzodiazepine receptors in an animal model of acute hepatic encephalopathy (1989) (27)
- Pathogenesis of hepatic encephalopathy. (2000) (26)
- Up-regulation of central mu-opioid receptors in a model of hepatic encephalopathy: a potential mechanism for increased sensitivity to morphine in liver failure. (2002) (26)
- The GABAA receptor complex in hepatic encephalopathy. Autoradiographic evidence for the presence of elevated levels of a benzodiazepine receptor ligand. (1990) (26)
- Profiles of serum complement in patients with hepatobiliary diseases. (1978) (25)
- The uptake of agalacto‐glucocerebrosidase by rat hepatocytes and kupffer cells (1978) (25)
- Alpha1-antitrypsin deficiency with cirrhosis associated with the protease inhibitor phenotype SZ. (1978) (24)
- Abnormal natural killer cytotoxicity in primary biliary cirrhosis: evidence for a functional deficiency of cytolytic effector cells. (1985) (23)
- Why do cholestatic patients itch? (1996) (23)
- Biosynthesis of the human C3b/C4b receptor during differentiation of the HL-60 cell line. Identification and characterization of a precursor molecule. (1984) (23)
- The pathogenesis and treatment of pruritus and fatigue in patients with PBC. (1999) (22)
- Incorporation of radiocopper into ceruloplasmin in normal subjects and in patients with primary biliary cirrhosis and Wilson's disease (1978) (22)
- Enzymes of Cerebral GABA Metabolism and Synaptosomal GABA Uptake in Acute Liver Failure in the Rabbit: Evidence for Decreased Cerebral GABA‐Transaminase Activity (1984) (22)
- The binding of plasma proteins to human placental cell membranes. (1977) (21)
- Flumazenil: potential implications for hepatic encephalopathy. (1990) (21)
- Changes in cerebral receptors for gamma aminobutyric acid in patients with hepatic encephalopathy. (2008) (18)
- Methods for assessing hepatic encephalopathy. (1983) (18)
- Modulation of thioacetamide-induced hepatocellular necrosis by prostaglandins is associated with novel histologic changes. (2008) (17)
- Defective immunoregulation in primary biliary cirrhosis: CD4+, Leu–8+ T cells have abnormal activation and suppressor function in vitro (1989) (17)
- Syndromatic hepatic ductular hypoplasia (arteriohepatic dysplasia) (1981) (17)
- Immunoglobulins and the gut. (1972) (17)
- Hepatocellular injury with distinctive mitochondrial changes induced by lergotrile mesylate: a dopaminergic ergot derivative. (1979) (17)
- Altered central serotoninergic neurotransmission: a potential mechanism for profound fatigue complicating chronic hepatitis C. (2001) (16)
- The disposition of 6‐deoxyacyclovir, a xanthine oxidase‐activated prodrug of acyclovir, in the isolated perfused rat liver (1987) (16)
- Shock wave-induced pancreatic trauma. (1991) (16)
- Encephalopathy and Nitrogen Metabolism in Liver Failure (2003) (16)
- Alpha-1-antitrypsin phenotypes in rheumatoid arthritis and systemic lupus erythematosus. (1979) (16)
- Circulating activated B cells in primary biliary cirrhosis (1985) (16)
- A comparative study of arteriography and scintillation scanning in space-occupying leions of the liver. (1968) (15)
- Reduced numbers of CD8+ T cells and B cell-expression of Leu-8 antigen in peripheral blood of patients with primary biliary cirrhosis. (1994) (14)
- Increased brain uptake of gamma-aminobutyric acid in a rabbit model of hepatic encephalopathy. (1990) (14)
- Trials of opiate antagonists for the pruritus of cholestasis: primary efficacy endpoints and opioid withdrawal-like reactions. (2002) (14)
- Visual Event-Related Potentials in Cirrhotic Patients Without Overt Encephalopathy: The Effects of Flumazenil (2001) (14)
- Treatment of pruritus caused by cholestasis with opioid antagonists. (2005) (13)
- NIH conference: Primary biliary cirrhosis: a model autoimmune disease. (1983) (13)
- Cell-mediated cytotoxicity of desialylated human lymphocytes induced by a mitogenic mammalian liver protein (1978) (13)
- Cell surface receptors in the liver. (1979) (13)
- Abnormal regulation of immunoglobulin synthesis in vitro in primary biliary cirrhosis. (1980) (13)
- A study of six patients with hypertrophy of the gastric mucosa with particular reference to albumin metabolism (1972) (13)
- Pruritus and fatigue associated with liver disease: is there a role for ondansetron? (2008) (12)
- Colonic bacteria: a source of gamma-aminobutyric acid in blood. (1981) (12)
- Corticosteroid-induced changes in urea metabolism in patients with hepatocellular disease. (1972) (12)
- Hepatic encephalopathy, GABA-ergic neurotransmission and benzodiazepine receptor ligands. (1990) (12)
- Sera from rabbits in acute hepatic coma inhibit the binding of (3H]γ-aminobutyric acid to neural membranes (1980) (10)
- Potential neural mechanisms in the pathogenesis of hepatic encephalopathy. (1982) (10)
- Studies of complement receptors on cytotoxic effector cells in human peripheral blood. (1978) (10)
- Benzodiazepine receptor ligands and the syndrome of hepatic encephalopathy. (1990) (10)
- Assessment of the Visual Analogue Score in the Evaluation of the Pruritus of Cholestasis (2017) (10)
- Sympathetic nerves, but not the adrenal gland, contribute to elevated plasma levels of met-enkephalin in rats with acute cholestatic hepatitis (1993) (10)
- Plasma endopeptidase 24.11 (enkephalinase) activity is markedly increased in cholestatic liver disease (1993) (9)
- Specific binding of human alpha interferon to high-affinity cell-surface binding sites on peripheral blood mononuclear cells. (1989) (9)
- Properties of receptors for IgG on human placental cell membranes. (1978) (9)
- Anticomplement receptor activity in the serum of patients with primary biliary cirrhosis. (1986) (9)
- Circulating immune complexes and the pathogenesis of primary biliary cirrhosis. (1982) (9)
- Metabolism of the inhibitory neurotransmitter gamma-aminobutyric acid in a rabbit model of fulminant hepatic failure. (1983) (9)
- Hepatic encephalopathy: a neurochemical disorder. (1986) (9)
- Alpha-1-antitrypsin deficiency and hepatocellular carcinoma. Determination of Pi phenotypes using iso-electric focusing. (1983) (8)
- The involvement of ammonia with the mechanisms that enhance GABA-ergic neurotransmission in hepatic failure. (1997) (8)
- Primary biliary cirrhosis: management of an unusual case with severe xanthomata by hepatic transplantation. (1989) (8)
- The selective hepatic uptake of desialylated peripheral blood mononuclear cells in rabbits (1980) (8)
- Resistance to 3-mercaptopropionic acid-induced seizures in hepatic encephalopathy. (1997) (8)
- Do benzodiazepine ligands contribute to hepatic encephalopathy? (1993) (8)
- The speciation of arsenic(V) and arsenic(III), by ion-exclusion chromatography, in solutions containing iron and sulphuric acid. (1991) (8)
- Studies of lysosomal function: I. Metabolism of some complex lipids by isolated hepatocytes and Kupffer cells. (1978) (7)
- Hepatic encephalopathy: new light on an old problem. (1988) (7)
- Further progress towards understanding hepatic sinusoidal cells. (1986) (6)
- Incorporation of radiocopper into ceruloplasmin in normal subjects and in patients with primary biliary cirrhosis and Wilson's disease. (1978) (6)
- Hepatic encephalopathy. (1989) (6)
- Functional aspects of hepatic sinusoidal cells. (1985) (6)
- Corticosteroid therapy for chronic active hepatitis. (1976) (6)
- The involvement of the benzodiazepine receptor in hepatic encephalopathy: evidence for the presence of a benzodiazepine receptor ligand. (1990) (5)
- Hepatic Encephalopathy and Benzodiazepine Receptor Ligands (1989) (5)
- Evidence for the presence of a benzodiazepine receptor binding substance in cerebrospinal fluid of a rabbit model of hepatic encephalopathy (1989) (5)
- Gamma-aminobutyric acid (GABAA) receptor-function in a rat model of hepatic encephalopathy (1990) (4)
- Brain cholecystokinin and vasoactive intestinal polypeptide: immunoreactivity in rabbits with hepatic coma. (2008) (4)
- A nonlinear kinetic model of γ-aminobutyric acid metabolism in a rabbit model of acute liver failure (1985) (4)
- L-Leucine prevents ammonia-induced changes in glutamate receptors in the brain and in visual evoked potentials in the rabbit. (1984) (4)
- Immunoglobulins and malabsorption. (1975) (4)
- The pruritus of cholestasis: evolving pathogenic concepts suggest new therapeutic options. (1998) (4)
- Visual event-related potentials in cirrhotic patients without overt encephalopathy (2000) (4)
- Visual Event-Related Potentials in Cirrhotic Patients without Overt Encephalopathy (2004) (4)
- Protease inhibitor phenotypes and pulmonary disease in patients with Sjögren's syndrome. (1981) (3)
- Studies of experimental hepatic encephalopathy (1985) (3)
- Cortical benzodiazepine receptor binding in a rabbit model of hepatic encephalopathy: The effect of Triton X-100 on receptor solubilization (1989) (3)
- Corticosteroid therapy for chronic active hepatitis. (1976) (3)
- Cell-mediated cytotoxicity of desialylated human lymphocytes induced by a mitogenic mammalian liver protein. (1978) (2)
- [Pathogenesis of hepatic encephalopathy--studies in the rabbit model of acute liver failure]. (1984) (2)
- [Autoradiography determination of the GABA(A) receptor density in the brain of rats with portacaval shunt]. (1990) (2)
- Defective proliferation and regulatory function of CD4+ T cells bearing Leu-8 homing receptor in primary biliary cirrhosis (1994) (2)
- 16, 16‐dimethyl prostaglandin E2 modulates aflatoxin B1‐induced injury of rat hepatocytes in primary culture: Possible role of cAMP (1992) (2)
- Liver cysts and abscesses (2004) (2)
- Identification of an acceptor system for gamma-aminobutyric acid on isolated rat hepatocytes. (1984) (2)
- Proceedings: Hypercatabolism of third component of complement in primary bilary cirrhosis. (1974) (2)
- Sclerosing peritonitis complicated by sepsis: a potential cause of portal hypertension. (1998) (2)
- The mechanism of intestinal uptake and transcellular transport of IgG in the neonatal rat. (1972) (2)
- The enigma of hepatic encephalopathy. (1983) (2)
- Concurrent Superficial Squamous Cell Carcinoma of the Esophagus and Early Gastric Adenocarcinoma. Report of a Case (1992) (2)
- Hemoperfusion-Induced Respiratory Distress Syndrome in an Animal Model: The Effects of Corticosteroids (1981) (2)
- Alpha-melanocyte-stimulating hormone in primary biliary cirrhosis. (1993) (1)
- The role of endogenous benzodiazepines in hepatic encephalopathy: animal studies. (1993) (1)
- Synaptic membrane complex carbohydrates in experimental hepatic encephalopathy (1990) (1)
- Hepatic scintillography. (1967) (1)
- Hepatic Encephalopathy is Associated with Decreased Numbers of Receptors for Excitatory Aminoacid Neurotransmitters (1984) (1)
- THE RAT WITH CARBON TETRACHLORIDE-INDUCED CIRRHOSIS AS A MODEL OF HEPATIC ENCEPHALOPATHY. (1989) (1)
- THE HEPATOTOXICITY OF ERGOT ALKALOIDS (1979) (1)
- Isolated CNS Neurons from a Model of Hepatic Encephalopathy Exhibit Increased Sensitivity to a Benzodiazepine (1989) (1)
- Differential uptake of native and desialylated glucocere-brosidase by rat hepatocytes and Kupffer cells (1978) (0)
- Familial hyperbilirubinaemia syndromes: kinetic approaches. (1989) (0)
- Anti-complement receptors in PBC in the clearance of complement coated cells in primary biliary cirrhosis (2006) (0)
- The mechanism of selective hepatic uptake of desialylated lymphocytes in the rabbit (1978) (0)
- The selective hepatic uptake of desialylated peripheral blood mononuclear cells in rabbits. (1980) (0)
- The Role of Natural Benzodiazepines Receptor Ligands in Hepatic Encephalopathy (2012) (0)
- A Glucose-Sensitive Glycoprotein Recognition System on Rat Hepatic Endothelial Cells (1982) (0)
- Effect of inhibition of ornithine decarboxylase activity in a model of acute hepatocellular necrosis (1998) (0)
- Rationale for treating pruritus complicating chronic liver disease with opiate antagonists (2004) (0)
- Recent trends in studies of the pathogenesis of hepatic encephalopathy (1985) (0)
- Selective hepatic uptakeofhumanf3-hexosaminidas (1979) (0)
- Primary biliary cirrhosis: a challenging disease for hepatologists and immunologists. (1981) (0)
- Molecular Biology of Hepatic Drug Reactions (1996) (0)
- Serum complement in chronic liver disease CH & * (2006) (0)
- Erratum to ‘Hepatic encephalopathy: molecular mechanisms underlying the clinical syndrome’ [J. Neurol. Sci. 170 (1999) 138–146] (2000) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Evan Anthony Jones?
Evan Anthony Jones is affiliated with the following schools:
